¼¼°èÀÇ ¹ÙÀÌ¿À ÀÓÇÇ´ø½º ºÐ¼®±â ½ÃÀå º¸°í¼­(2025³â)
Bioimpedance Analyzers Global Market Report 2025
»óǰÄÚµå : 1702942
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,156,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 8,898,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,640,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¹ÙÀÌ¿À ÀÓÇÇ´ø½º ºÐ¼®±â ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È ºü¸£°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â±îÁö 14.1%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î 11¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ¼ºÀåÀº ÀÇ·á ÀÎÇÁ¶óÀÇ ¼ºÀå, ÀÚ±Ý Á¶´Þ ¹× ÀÌ´Ï¼ÅÆ¼ºê Áõ°¡, °Ç°­ ÀÎ½Ä Áõ°¡, ÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ ÁöÃâ Áõ°¡, Á¤Å© Ǫµå ¼Òºñ Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ±â¼ú ¹ßÀü, °³ÀÎÈ­µÈ ÇコÄÉ¾î ¼Ö·ç¼Ç, ¿ø°Ý ÀÇ·á ¼­ºñ½º äÅÃ, ºñħ½ÀÀû ±â¼ú, ¿þ¾î·¯ºí ±â¼ú°úÀÇ ÅëÇÕ µîÀÌ ÀÖ½À´Ï´Ù.

ºñ¸¸¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¹ÙÀÌ¿À ÀÓÇÇ´ø½º ºÐ¼®±â ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. °Ç°­¿¡ ¾Ç¿µÇâÀ» ¹ÌÄ¡´Â üÁö¹æÀÇ °úµµÇÑ ÃàÀûÀ» Ư¡À¸·Î ÇÏ´Â ºñ¸¸Àº °í¿­·®, °íÁö¹æ, °í´çºÐ ½ÄǰÀÌ ³Î¸® º¸±ÞµÇ¸é¼­ ¾É¾Æ¼­ »ýȰÇÏ´Â »ýȰ½À°ü°ú ¿îµ¿·® °¨¼Ò·Î ÀÎÇØ Á¡Á¡ ´õ ¸¸¿¬Çϰí ÀÖ½À´Ï´Ù. »ýü ÀÓÇÇ´ø½º ºÐ¼®±â´Â ü¼ººÐ¿¡ ´ëÇÑ »ó¼¼ÇÏ°í ½Ç¿ëÀûÀÎ µ¥ÀÌÅ͸¦ Á¦°øÇÔÀ¸·Î½á ºñ¸¸ °ü¸®¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÀÌ Á¤º¸´Â °³ÀÎ ¸ÂÃãÇü Ä¡·á °èȹÀ» Áö¿øÇϰí, °Ç°­ À§ÇèÀ» ¸ð´ÏÅ͸µÇϰí, ȯÀÚÀÇ µ¿±â¸¦ ºÎ¿©Çϰí, ü¾× ±ÕÇüÀ» Æò°¡Çϰí, ÀÓ»ó °á°ú¸¦ °³¼±Çϰí, ¿¬±¸ ³ë·ÂÀ» °­È­ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 3¿ù, ½ºÀ§½º¿¡ º»ºÎ¸¦ µÐ ½ÉÇ÷°ü Ä¿¹Â´ÏƼ Á¶Á÷ÀÎ ¼¼°è ½ÉÀå Àç´ÜÀº Àü ¼¼°èÀûÀ¸·Î ¾à 23¾ï ¸íÀÇ ¼ºÀΰú ¾î¸°À̰¡ ºñ¸¸ ¶Ç´Â °úüÁßÀ̶ó°í º¸°íÇß½À´Ï´Ù. ÇöÀç Ãß¼¼´ë·Î¶ó¸é ÀÌ ¼öÄ¡´Â 2025³â±îÁö 27¾ï ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±× °á°ú, ºñ¸¸¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ¹ÙÀÌ¿À ÀÓÇÇ´ø½º ºÐ¼®±â ½ÃÀåÀÇ ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.

»ýü ÀÓÇÇ´ø½º ºÐ¼®±â ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷µéÀº º¸´Ù Á¤È®ÇÑ °Ç°­ Æò°¡¸¦ Á¦°øÇÏ°í »ç¿ëÀÚÀÇ ÆíÀǼºÀ» ³ôÀ̱â À§ÇØ Ã¼¼ººÐ ºÐ¼®±â¿Í °°Àº ÷´Ü Á¦Ç° °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ü¼ººÐ ºÐ¼®±â´Â »ýü ÀÓÇÇ´ø½º ºÐ¼®(BIA)À» »ç¿ëÇÏ¿© ü¼ººÐÀÇ ´Ù¾çÇÑ ¼ººÐÀ» ÃßÁ¤ÇÏ¿© ´Ü¼øÇÑ Ã¼Áß ÀÌ»óÀÇ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 9¿ù Áß±¹ ÀüÀÚ ±â¾÷ »þ¿À¹Ì´Â 8Àü±Ø ü¼ººÐ ÃøÁ¤±â¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ Çõ½ÅÀûÀΠüÁß°è´Â ÀÌÁß Á֯ļö »ýü ÀÓÇÇ´ø½º ÃøÁ¤ ±â¼úÀ» äÅÃÇÏ¿© ±âÁ¸ÀÇ ´ÜÀÏ Á֯ļö üÁß°è¿¡ ºñÇØ ´õ ³ôÀº Á¤È®µµ·Î ÃÖ´ë 35 °³ÀÇ Ã¼¼ººÐ º¸°í¼­¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ Ã¼Áß°è´Â ´ÙÁÖÆÄ »ýü ±³·ù Àü·ù¸¦ ÀÌ¿ëÇÏ¿© üÁö¹æ, ¼öºÐ, ±ÙÀ° ¹× ±âŸ ½Åü ÁöÇ¥¸¦ Á¤È®ÇÏ°Ô ÃøÁ¤ÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÇü Äڷγª¹ÙÀÌ·¯½º, ±×¸®°í °æ±âȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Bioimpedance analyzers are devices designed to measure the electrical impedance of biological tissues, primarily for assessing body composition. They operate by passing a small, safe electrical current through the body and measuring how the current's flow is impeded, which varies with different types of tissues.

The primary types of bioimpedance analyzers are multi-frequency, single-frequency, and dual-frequency. Multi-frequency analyzers use various frequencies of electrical current to assess body composition. The available modalities include wired and wireless bioimpedance. These analyzers are applied in whole-body and segmental body measurements, and are used by hospitals, fitness clubs, wellness centers, home users, and others.

The bioimpedance analyzers market research report is one of a series of new reports from The Business Research Company that provides bioimpedance analyzers market statistics, including bioimpedance analyzers industry global market size, regional shares, competitors with a bioimpedance analyzers market share, detailed bioimpedance analyzers market segments, market trends, and opportunities, and any further data you may need to thrive in the bioimpedance analyzers industry. This bioimpedance analyzer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bioimpedance analyzers market size has grown rapidly in recent years. It will grow from $0.59 billion in 2024 to $0.67 billion in 2025 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be attributed to the growing obesity epidemic, changing lifestyles and an increase in home delivery, rising prevalence of blood disorders such as anemia, and leukemia, prevalence of chronic diseases, and growing geriatric population.

The bioimpedance analyzers market size is expected to see rapid growth in the next few years. It will grow to $1.14 billion in 2029 at a compound annual growth rate (CAGR) of 14.1%. The growth in the forecast period can be attributed to growth in healthcare infrastructure, increasing funding and initiatives, increasing health awareness, growing spending on healthcare services, and rising consumption of junk foods. Major trends in the forecast period include technological advancements, personalized healthcare solutions, adoption of telehealth services, non-invasive technologies, and integration with wearable technology.

The growing concerns over obesity are anticipated to drive the expansion of the bioimpedance analyzers market. Obesity, characterized by an excessive accumulation of body fat that adversely affects health, is increasingly prevalent due to the widespread availability of high-calorie, high-fat, and high-sugar foods, along with sedentary lifestyles and decreased physical activity. Bioimpedance analyzers play a crucial role in managing obesity by providing detailed and actionable data on body composition. This information supports personalized treatment plans, monitors health risks, motivates patients, assesses fluid balance, improves clinical outcomes, and enhances research efforts. For instance, in March 2023, the World Heart Foundation, a Switzerland-based cardiovascular community organization, reported that approximately 2.3 billion adults and children globally are obese or overweight. If current trends continue, this number is projected to reach 2.7 billion by 2025. Consequently, increasing concerns about obesity are fueling growth in the bioimpedance analyzers market.

Leading companies in the bioimpedance analyzer market are focusing on developing advanced products, such as body composition scales, to provide more accurate health assessments and enhance user convenience. A body composition scale uses bioimpedance analysis (BIA) to estimate various components of body composition, offering insights beyond simple body weight. For example, in September 2022, Xiaomi, a China-based electronics company, introduced its eight-electrode body composition scale. This innovative scale employs dual-frequency bioimpedance measurement technology, enabling it to deliver up to 35 body composition reports with greater accuracy compared to traditional single-frequency scales. The scale utilizes multi-frequency biological alternating current to accurately measure body fat, water, muscle, and other body indices.

In June 2022, PharmaNutra S.p.A., an Italy-based nutritional company, acquired Akern S.r.l. for an undisclosed amount. This acquisition allows PharmaNutra to leverage Akern's established research and development capabilities and distribution network, thereby diversifying its business operations and enhancing its competitiveness in the nutritional supplement and medical device markets. Akern, based in Italy, specializes in manufacturing bioimpedance analyzers.

Major companies operating in the bioimpedance analyzers market are Xiaomi Corporation, Omron Corporation, Beurer GmbH, InBody Co Ltd., Seca GmbH & Co., Withings, Lumsail Industrial Inc., Zurich Instruments Ltd., RJL Systems Inc., ImpediMed Limited, Biodynamics Corporation, Charder Electronic Co Ltd., Akern Srl, Bioparhom, BioTekna Limited, Bodystat Ltd., EVOLT 360 Limited, Maltron International Ltd., Tanita Corporation, Tongfang Health Technology (Beijing) Co.Ltd

North America was the largest region in the bioimpedance analyzer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioimpedance analyzers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bioimpedance analyzers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bioimpedance analyzers market consists of sales of bioimpedance spectroscopy, segmental bioimpedance analyzers, handheld bioimpedance analyzers, and clinical-grade bioimpedance analyzers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bioimpedance Analyzers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bioimpedance analyzers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for bioimpedance analyzers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bioimpedance analyzers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Bioimpedance Analyzers Market Characteristics

3. Bioimpedance Analyzers Market Trends And Strategies

4. Bioimpedance Analyzers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Bioimpedance Analyzers Growth Analysis And Strategic Analysis Framework

6. Bioimpedance Analyzers Market Segmentation

7. Bioimpedance Analyzers Market Regional And Country Analysis

8. Asia-Pacific Bioimpedance Analyzers Market

9. China Bioimpedance Analyzers Market

10. India Bioimpedance Analyzers Market

11. Japan Bioimpedance Analyzers Market

12. Australia Bioimpedance Analyzers Market

13. Indonesia Bioimpedance Analyzers Market

14. South Korea Bioimpedance Analyzers Market

15. Western Europe Bioimpedance Analyzers Market

16. UK Bioimpedance Analyzers Market

17. Germany Bioimpedance Analyzers Market

18. France Bioimpedance Analyzers Market

19. Italy Bioimpedance Analyzers Market

20. Spain Bioimpedance Analyzers Market

21. Eastern Europe Bioimpedance Analyzers Market

22. Russia Bioimpedance Analyzers Market

23. North America Bioimpedance Analyzers Market

24. USA Bioimpedance Analyzers Market

25. Canada Bioimpedance Analyzers Market

26. South America Bioimpedance Analyzers Market

27. Brazil Bioimpedance Analyzers Market

28. Middle East Bioimpedance Analyzers Market

29. Africa Bioimpedance Analyzers Market

30. Bioimpedance Analyzers Market Competitive Landscape And Company Profiles

31. Bioimpedance Analyzers Market Other Major And Innovative Companies

32. Global Bioimpedance Analyzers Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bioimpedance Analyzers Market

34. Recent Developments In The Bioimpedance Analyzers Market

35. Bioimpedance Analyzers Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â